3B BlackBio Dx Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

7.49

7.49

7.49

7.49

6.39

Share application money

-

-

-

-

4.40

Preference share capital

-

-

-

-

-

Reserves & surplus

16.73

16.44

15.16

13.29

4.95

Loan funds

Secured loans

2.03

2.53

2.00

3.52

4.16

Unsecured loans

-

-

-

-

2.03

Total

26.25

26.46

24.66

24.30

21.93

Uses of funds

Fixed assets

Gross block

7.62

7.65

6.13

5.99

5.78

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

4.62

4.43

4.16

4.02

3.61

Net block

3.00

3.23

1.97

1.97

2.17

Capital work-in-progress

0.09

0.11

0.13

0.20

0.10

Investments

3.60

3.60

3.60

3.60

1.35

Net current assets

Current assets, loans & advances

23.16

24.66

23.18

22.41

23.08

Less : current liabilities & provisions

3.61

5.14

4.23

3.87

4.77

Total net current assets

19.55

19.52

18.95

18.54

18.31

Miscellaneous expenses not written

-

-

-

-

-

Total

26.25

26.46

24.66

24.30

21.93

Notes:

Book value of unquoted investments

3.60

3.60

3.60

3.60

1.35

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

544.31

4.66

5.07

0.42

0.75

Number of equity sharesoutstanding (Lacs)

75.08

75.08

75.08

75.08

64.08